日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

CLT030, a leukemic stem cell-targeting CLL1 antibody-drug conjugate for treatment of acute myeloid leukemia.

CLT030 是一种靶向白血病干细胞的 CLL1 抗体药物偶联物,用于治疗急性髓系白血病

Jiang Ying-Ping, Liu Bob Y, Zheng Quan, Panuganti Swapna, Chen Ruoying, Zhu Jianyu, Mishra Madhavi, Huang Jianqing, Dao-Pick Trang, Roy Sharmili, Zhao XiaoXian, Lin Jeffrey, Banik Gautam, Hsi Eric D, Mandalam Ramkumar, Junutula Jagath R